108 related articles for article (PubMed ID: 18097470)
1. Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
Li HL; Li S; Shao JY; Lin XB; Cao Y; Jiang WQ; Liu RY; Zhao P; Zhu XF; Zeng MS; Guan ZZ; Huang W
Gene Ther; 2008 Feb; 15(4):247-56. PubMed ID: 18097470
[TBL] [Abstract][Full Text] [Related]
2. [Clinical tolerance trial on recombinant human endostatin adenovirus].
Cao Y; Li S; Li HL; Li YH; Zhang DS; Guo Y; Li XL; Lin XB; Huang WL; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):856-60. PubMed ID: 17697547
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors.
Lin X; Huang H; Li S; Li H; Li Y; Cao Y; Zhang D; Xia Y; Guo Y; Huang W; Jiang W
Cancer Biol Ther; 2007 May; 6(5):648-53. PubMed ID: 17426445
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
Li JL; Liu HL; Zhang XR; Xu JP; Hu WK; Liang M; Chen SY; Hu F; Chu DT
Gene Ther; 2009 Mar; 16(3):376-82. PubMed ID: 19092859
[TBL] [Abstract][Full Text] [Related]
6. Dynamic distribution and expression in vivo of human endostatin gene delivered by adenoviral vector.
He GA; Xue G; Xiao L; Wu JX; Xu BL; Huang JL; Liang ZH; Xiao X; Huang BJ; Liu RY; Huang W
Life Sci; 2005 Aug; 77(12):1331-40. PubMed ID: 15936041
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity and stability analysis of endostatin purified from fermentation supernatant of 293 cells transfected with Ad/rhEndo.
Liang Z; Wu J; Huang J; Tan W; Ke M; Liu R; Huang B; Xiao X; Zhao P; Huang W
Protein Expr Purif; 2007 Dec; 56(2):205-11. PubMed ID: 17933553
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
9. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.
Cunningham CC; Chada S; Merritt JA; Tong A; Senzer N; Zhang Y; Mhashilkar A; Parker K; Vukelja S; Richards D; Hood J; Coffee K; Nemunaitis J
Mol Ther; 2005 Jan; 11(1):149-59. PubMed ID: 15585416
[TBL] [Abstract][Full Text] [Related]
10. Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
Palmer DH; Mautner V; Mirza D; Oliff S; Gerritsen W; van der Sijp JR; Hubscher S; Reynolds G; Bonney S; Rajaratnam R; Hull D; Horne M; Ellis J; Mountain A; Hill S; Harris PA; Searle PF; Young LS; James ND; Kerr DJ
J Clin Oncol; 2004 May; 22(9):1546-52. PubMed ID: 15051757
[TBL] [Abstract][Full Text] [Related]
11. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
Triozzi PL; Allen KO; Carlisle RR; Craig M; LoBuglio AF; Conry RM
Clin Cancer Res; 2005 Jun; 11(11):4168-75. PubMed ID: 15930353
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
Khorana AA; Rosenblatt JD; Sahasrabudhe DM; Evans T; Ladrigan M; Marquis D; Rosell K; Whiteside T; Phillippe S; Acres B; Slos P; Squiban P; Ross M; Kendra K
Cancer Gene Ther; 2003 Apr; 10(4):251-9. PubMed ID: 12679797
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients.
Griscelli F; Opolon P; Saulnier P; Mami-Chouaib F; Gautier E; Echchakir H; Angevin E; Le Chevalier T; Bataille V; Squiban P; Tursz T; Escudier B
Gene Ther; 2003 Mar; 10(5):386-95. PubMed ID: 12601393
[TBL] [Abstract][Full Text] [Related]
15. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
[TBL] [Abstract][Full Text] [Related]
16. Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene.
Huang BJ; Liu RY; Huang JL; Liang ZH; Gao GF; Wu JX; Huang W
Hum Gene Ther; 2007 Mar; 18(3):207-21. PubMed ID: 17346097
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral vector-mediated expression of endostatin inhibits tumor growth and metastasis in an orthotropic pancreatic cancer model in hamsters.
Noro T; Miyake K; Suzuki-Miyake N; Igarashi T; Uchida E; Misawa T; Yamazaki Y; Shimada T
Cancer Res; 2004 Oct; 64(20):7486-90. PubMed ID: 15492274
[TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
Thomas JP; Arzoomanian RZ; Alberti D; Marnocha R; Lee F; Friedl A; Tutsch K; Dresen A; Geiger P; Pluda J; Fogler W; Schiller JH; Wilding G
J Clin Oncol; 2003 Jan; 21(2):223-31. PubMed ID: 12525513
[TBL] [Abstract][Full Text] [Related]
19. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.
Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H
J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
